A case of autoimmune chronic active hepatitis with unusual extrahepatic manifestations is described. The patient exhibited marked thrombocytopenia and platelet aggregation dysfunction and morphological changes suggesting an acquired Bernard Soulier-type syndrome. This has not previously been described in association with chronic active hepatitis. The patient also demonstrated significant titres of anti-cardiolipin antibodies. This is also a new finding in association with both the liver and platelet diseases. The platelet aggregation deficit was transferable in the patient's serum rather than being intrinsic to the platelets. The three previously reported cases of acquired Bernard Soulier are reviewed and possible mechanisms for the platelet dysfunction are discussed.
Introduction
Autoimmune chronic active hepatitis is an uncommon disease and, although the aetiology and pathogenesis are not yet defined,' immune-related damage is important and widespread immunological abnormalities have been described.2 A variety of abnormalities of platelet morphology and function are documented in association with various forms ofliver disease, some ofthese are due to deficits in immunological regulation. 3`5 This case report describes the association of autoimmune chronic active hepatitis with both an acquired platelet defect resembling BernardSoulier syndrome and the presence of anticardiolipin antibody. Acquired platelet abnormalities comprising thrombocytopenia, abnormal morphology and impaired aggregation likened to a pseudo-Bernard -Soulier syndrome have been seen previously in only three cases each with a different association, and an autoimmune basis may have been involved.8 Anti-cardiolipin antibody has also been described in association with a variety of conditions often with an autoimmune basis or tissue destruction.9 Although associated thrombocytopenia is often recognized, the pseudoBernard-Soulier changes have not been described previously.
Case report
A 30 year old female of West Indian origin presented with a one month history of jaundiced sclerae, dark urine, malaise and anorexia. Her past medical history was unremarkable and there were no recognized risk factors for liver disease in her social, sexual or drug history. Examination revealed jaundice, 4 The thrombocytopenia showed wide fluctuations, on occasions normal counts and morphology were seen but most of the time giant platelets were present. A blood film 2 years previously was reviewed and found to be normal. Examination of the bone marrow showed plentiful but abnormal megakaryocytes with great variation in size and apparent failure of platelet separation. Large megakaryocytic inclusions were seen approximating in size to the giant platelets in peripheral blood. The other cell lineages were normal. Electron microscopy of platelets was normal.
Platelet aggregation with all standard agents (ristocetin, adrenaline, collagen, adenosine diphosphate) was impaired and not corrected by mixing 50:50 with normal plasma. The Russell viper test for lupus anticoagulant was negative. High titres of platelet-associated immunoglobulin were detected by immunofluorescence."1 Levels of factor VIII:C and von Willebrand factor were normal.
Treatment with prednisolone 20 mg daily was commenced with symptomatic improvement. After 3 months therapy relevant results were: platelets 204 x 109/1; AST 290 IU/l; IgG 54.2 g/l; anticardiolipin antibody IgG positive at 24 units; anti-LSP> 1:2,400; anti-ASGP-R 1:1,300. Very occasional giant platelets were seen on the blood film.
The aggregation studies were repeated. Ristocetin aggregation was absent, collagen-induced aggregation reduced, other agonists normal. Aggregation with ristocetin was restored by suspending the patient's washed platelets in control plasma. The patient's plasma abolished ristocetin-induced aggregation of normal platelets. antibody may have been generated as a nonspecific response to tissue injury, in this case hepatitis, as has been described following myocardial infarction rather than as an integral part of the autoimmune disease. 20 Thrombocytopenia of varied degree is common in liver disease and is multifactorial in origin.2' In this case the thrombocytopenia, large abnormal platelets and impaired aggregation are suggestive of Bernard Soulier syndrome. 22 The bleeding time was normal, a blood film 2 years previously was normal and there were no significant abnormalities on her parents' blood films, indicating she did not have true inherited Bernard Soulier or von Willebrand's disease. The aggregation defect and morphology are not normally found in autoimmune thrombocytopoenic purpura (ITP). 23 There are three previous reports of an acquired pseudo-Bernard Soulier each with slightly different features and associations. One was found with juvenile myelodysplasia6 and one each with a lymphoproliferative disorder7 and procainamideinduced lupus.8 These acquired disorders showed impaired aggregation to ristocetin alone amongst the standard agonists and thrombocytopenia and the morphological changes were not consistent between the three cases. In contrast this case showed a wider scope of platelet function defect
Discussion
with impaired aggregation to all agonists. The exact changes in inherited and acquired Bernard Soulier remain unclear.22 The mechanism ofthrombocytopenia in this case may be multifactorial, despite the absence of splenomegaly splenic pooling could contribute.2' Platelet-associated immunoglobulins (PA-Ig) are common in aCAH and thrombocytopenia is rare in the absence of PA-Ig. '5 In contrast to autoimmune thrombocytopenic purpura there is no correlation between antibody titre and platelet count.'5 In addition to antibody directed against platelet antigens some PA-Ig is found as immune complexes binding non-specifically to platelet Fc receptors. Both types of PA-Ig are associated with thrombocytopenia and are difficult to differentiate by standard immunofluorescence techniques.24 '25 In the presence of severe hypergammaglobulinaemia and complement consumption, it is possible that immune complex binding (with target antigen unclear) with subsequent complement activation and specific anti-platelet antibodies are both contributing to platelet destruction.
The platelet defect in Bernard Soulier syndrome involves a deficiency in glycoprotein Ib/IX preventing interaction in Von Willebrand factor dependent adhesion to the sub-endothelium. 26 The aggregation studies in this patient show that the abnormality is transmissible in the serum rather than the platelets themselves. It seems likely an autoantibody is responsible in this case. Antibody directed against gp Ib/IX has been documented in immune thrombocytopenia without the described morphological change or aggregation deficit. 27 Of the three cases of pseudo-Bernard Soulier, two demonstrated transmission of the impaired ristocetin response in the immunoglobulin fraction7'8 (in the other the defect was in the platelet). Both of these cases showed PA-Ig. One of these antibodies was directed against an epitope which did not seem to be gp Ib/IX,7 in the other gp I may have been the target. 8 Given the widespread immunological abnormalities in this case it seems likely that PA-Ig was involved in the aggregation defect. The impaired response was to a range of agonists rather than just ristocetin. It is possible that there are different antibodies directed against different platelet membrane antigens involved in the aggregation responses. It has not yet been possible to characterize the target antigens. It has been suggested that in ITP there may be more than one platelet target site per patient.28 Previously antibody-associated platelet dysfunction without the pseudo-Bernard Soulier changes have been described, although the targets antigens were not identified.29 The bone marrow appearances may reflect anti-platelet/ megakaryocyte antibody action although there is no direct evidence of this.
The immunopathogenesis of aCAH is not specifically defined. Widespread immunological abnormalities in extrahepatic systems are known. This is the first case associated with anti-cardiolipin antibody, although the significance of this in relation to the disease and thrombocytopenia is unclear. Platelet morphological and functional deficits described in this case fit with the few previous cases of pseudo-Bernard Soulier syndrome and appear to be antibody mediated. The target antibodies have not been fully defined. This is the first case of acquired Bernard Soulier associated with autoimmune chronic active hepatitis and should lead to greater consideration of anti-platelet antibodies in aCAH.
